Form 8-K - Current report:
SEC Accession No. 0001213900-20-000838
Filing Date
2020-01-13
Accepted
2020-01-13 07:00:48
Documents
12
Period of Report
2020-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k011320_nektar.htm   iXBRL 8-K 25738
  Complete submission text file 0001213900-20-000838.txt   198067

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nktr-20200113.xsd EX-101.SCH 3170
3 XBRL LABEL FILE nktr-20200113_lab.xml EX-101.LAB 34581
4 XBRL PRESENTATION FILE nktr-20200113_pre.xml EX-101.PRE 22696
9 EXTRACTED XBRL INSTANCE DOCUMENT f8k011320_nektar_htm.xml XML 3497
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 20522720
SIC: 2834 Pharmaceutical Preparations